Heteroaryl comprising N derivatives and pharmaceutical composition for use in preventing or treating cancer containing the same as an active ingredient
KR20200133188A
Heterocycle-fused pyrimidine derivatives and use thereof
KR20200105631A
Heteroaryl comprising N derivatives and pharmaceutical composition containing the same as an active ingredient
KR20200090636A
A pyrrolopyrimidine derivatives, and pharmaceutical composition for use in preventing or treating protein kinase related disease as an active ingredient
WO2020013531A1
N-(3-(imidazo[1,2-b]pyridazine-3-ylethynyl)-4-methylphenyl)-5-phenyl-4,5-dihydro-1h-pyrazole-1-carboxamide derivative, and pharmaceutical composition containing same as active ingredient for treating kinase-related diseases
KR20200137088A
Novel 5-(3,6-dihydro-2H-pyran-4-yl)-4-substituent-N-(1-substituent-1H-pyrazol-4-yl)(N-heteroaryl)-2-amine derivatives and use thereof
KR20200137087A
Novel 4-substituent-N-(1-substituent-1H-pyrazol-4-yl)-5-morpholinopyrimidin-2-amine derivatives and use thereof
KR20200132317A
Novel 3-(substituted amino)-6-alkyl-pyrazine-2-carboxamide derivatives and use thereof
WO2019177375A1
2, 4, 5-substituted pyrimidine derivatives, method for preparing same, and pharmaceutical composition for preventing or treating cancer comprising same as active ingredient
KR20190108080A
2,4,5-substituted pyrimidine derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating cancer or inflammatory disease in containing the same as an active ingredient
KR20200105592A
4-((1H-pyrazol-3-yl)amino)phthalazin-1(2H)-one derivatives and pharmaceutical composition for use in preventing or treating cancer containing the same as an active ingredient
KR20200088945A
benzo[b][1,4]oxazepin derivatives and pharmaceutical composition for use in preventing or treating kinase-related disease
KR20200087922A
(3-phenylisoxazolidin-2-yl)(piperidin-4-yl)methanone derivatives and pharmaceutical composition for use in preventing or treating kinase-related disease
